Effect of achillea Mellifolium in Ischemic Stroke

Comparison of the effect of achillea millefolium on disability and functional state of ischemic stroke patients, A clinical trial study

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190129042540N2

Enrollment

110

Registered

2023-04-26

Start date

2023-04-21

Completion date

Unknown

Last updated

2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic stroke. Cerebral infarction

Interventions

Intervention 1: Treatment group: Stroke patients are randomly assigned to the treatment group. People in this group receive yarrow capsules. Capsules in a dose of 500 mg are prepared from the aqueous

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: ischemic stroke for the first time satisfy to participate nihss less than 25 age more than 18

Exclusion criteria

Exclusion criteria: The use of alteplase in treatment impaired swallowing pregnancy or intend to be pregnant using other herbal medicine allergy to achillea millefolium

Design outcomes

Primary

Measure	Time frame
Disability scale. Timepoint: First and 3 months later. Method of measurement: Questionnaire of NIHS.	—

Secondary

Measure	Time frame
Functional state. Timepoint: First and 3 months later. Method of measurement: Questionnaire of Modified Rankin Scale (mRS).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAlireza Vakilian

Rafsanjan University of Medical Sciences

alirezavakilian66@rums.ac.ir+98 34 3428 9393

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026